Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Chao-Jen Wong und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Biology, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109, United States. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Identifying the aberrant expression of DUX4 in skeletal muscle as the cause of facioscapulohumeral dystrophy (FSHD) has led to rational therapeutic development and clinical trials. Several studies support the use of MRI characteristics and the expression of DUX4-regulated genes in muscle biopsies as biomarkers of FSHD disease activity and progression. We performed lower-extremity MRI and muscle biopsies in the mid-portion of the tibialis anterior (TA) muscles bilaterally in FSHD subjects and validated our prior reports of the strong association between MRI characteristics and expression of genes regulated by DUX4 and other gene categories associated with FSHD disease activity. We further show that measurements of normalized fat content in the entire TA muscle strongly predict molecular signatures in the mid-portion of the TA, indicating that regional biopsies can accurately measure progression in the whole muscle and providing a strong basis for inclusion of MRI and molecular biomarkers in clinical trial design. An unanticipated finding was the strong correlations of molecular signatures in the bilateral comparisons, including markers of B-cells and other immune cell populations, suggesting that a systemic immune cell infiltration of skeletal muscle might have a role in disease progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Biology, Fred Hutchinson Cancer Center, 1100 Fairview Ave N, Seattle, WA 98109, United States.
- Department of Radiology, Seattle Children's Hospital, 4540 Sandpoint Way, Seattle, WA 98105, United States.
- Department of Pharmacology, University of Nevada, Reno School of Medicine, 1664 North Virginia Street, Reno, NV 89557, United States.
- Springbok Analytics, 100 W South St, Charlottesville, VA 22902, United States.
- Department of Human Genetics, Leiden University Medical Center, Einthovenweg 20, 2333 ZC Leiden, The Netherlands.
- Department of Neurology, University of Washington, 1959 NE Pacific St, Seattle, WA 98105, United States.
ORCID-Profile: Peter L Jones, Olivia DuCharme, Richard J F L Lemmers, Stephen J Tapscott
Förderung
- NIAMS NIH HHS
- NIH HHS
- National Institutes of Health
- Friends of FSH Research
Zitieren
APA
Wong, C. J., Friedman, S. D., Snider, L., Bennett, S. R., Jones, T. I., Jones, P. L., Shaw, D. W. W., Blemker, S. S., Riem, L., DuCharme, O., Lemmers, R. J. F. L., van der Maarel, S. M., Wang, L. H., Tawil, R., Statland, J. M., & Tapscott, S. J. (2024). Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae007
Vancouver
Wong CJ, Friedman SD, Snider L, Bennett SR, Jones TI, Jones PL, et al. Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae007
BibTeX
@article{Wong2024,
author = {Wong, Chao-Jen and Friedman, Seth D and Snider, Lauren and Bennett, Sean R and Jones, Takako I and Jones, Peter L and Shaw, Dennis W W and Blemker, Silvia S and Riem, Lara and DuCharme, Olivia and Lemmers, Richard J F L and van der Maarel, Silvère M and Wang, Leo H and Tawil, Rabi and Statland, Jeffrey M and Tapscott, Stephen J},
title = {Regional and bilateral MRI and gene signatures in facioscapulohumeral dystrophy: implications for clinical trial design and mechanisms of disease progression},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae007}
}
EUVIMED